Inhibition of autophagy alleviates the senescent state of rat mesenchymal stem cells during long-term culture

  • Authors:
    • Yong Zheng
    • Cheng-Jun Hu
    • Ru-Hong Zhuo
    • Yue-Shan Lei
    • Na-Na Han
    • Liu He
  • View Affiliations

  • Published online on: October 10, 2014     https://doi.org/10.3892/mmr.2014.2624
  • Pages: 3003-3008
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Following a limited number of cell divisions, mesenchymal stem cells (MSCs) undergo senescence, and these senescent cells maintain metabolic modification and remain viable for long periods. Autophagy, an intracellular bulk degradation process, provides a survival effect for cells under stress. In this study, the effect of autophagy on senescent MSCs was analyzed. Following serial passaging, rat MSCs underwent replicative senescence, characterized by positive staining for senescence-associated β-galactosidase (SA-β-gal), and increased expression levels of p16 and p21. During MSC senescence, the levels of autophagic activity were increased, a greater number of autophagic vacuoles were observed in senescent MSCs by transmission electron microscopy, acridine orange staining was elevated and the expression levels of autophagy‑related proteins (microtubule‑associated protein 1A/1B‑light chain 3-II, Atg7 and Atg12) were increased. The role of autophagy in MSC senescence was further investigated through pharmacological inhibition of autophagy with bafilomycin A1 and 3-methyladenine. Inhibition of autophagy by pharmacological means reduced the rate of positive staining for SA-β-gal and the expression levels of senescence‑related proteins. In conclusion, these findings suggest that autophagy is activated during senescence and the autophagic activity may be a requirement for maintaining the senescent state of MSCs.

Introduction

Mesenchymal stem cells (MSCs), the most promising autologous cell source, show great promise in various clinical applications (1,2). However, MSCs in bone marrow are rare populations that require extensive in vitro expansion prior to clinical use. Futhermore, MSCs reach replicative senescence subsequent to a certain number of cell divisions as normal somatic cells. The senescent cells develop an enlarged and flat senescent morphology and ultimately stop division. In addition, senescent MSCs exhibit reduced differentiation potential, which limits the application of MSCs in therapeutic and tissue engineering (3).

Senescent cells are known to remain viable for long periods and secrete large quantities of proteins, which reinforces the senescence phenotype and establishes the senescence-associated secretory phenotype (4). This protein remodeling is coupled with another cell process, autophagy (5), which is an evolutionarily conserved mechanism mediating the turnover of a diverse set of cytoplasmic components, including abnormal intracellular proteins and damaged organelles (6). Previous studies have indicated that changes in the activity of the autophagic system are involved in numerous age-related diseases, such as Alzheimer’s, Parkinson’s and Huntington’s disease (7).

Autophagy and senescence are two closely associated biological phenomena, which may be induced through external or internal forms of stress, including DNA damage, radiation, chemotherapy and telomere shortening (8). Recently, Goehe et al (9) reported that autophagy and senescence are regulated by overlapping signaling pathways involving the generation of reactive oxygen species, induction of p53 and p21, and dephosphorylation of retinoblastoma protein. However, the potential roles of autophagy during senescence remain unclear.

Materials and methods

Cell culture

Animal experimental procedures were approved by the Institutional Animal Care Committee of Wuhan University (Wuhan, China). Bone marrow MSCs were isolated from the femora and tibiae of Sprague Dawley rats (160–180 g) using a previously described method (10,11). The rats were supplied by the Experimental Animal Center of Wuhan University (Wuhan, China). Briefly, following sacrifice under ether (3%) anesthesia, the ends of the bones were cut open and the bone marrow was flushed with ~4 ml culture medium using a sterile syringe. The MSCs were seeded in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum and penicillin (100 U/ml)/streptomycin (100 mg/ml). The culture medium was replaced once every 24 h three times in order to remove non-adherent cells. Subsequently, the culture medium was changed every three days. When the cells reached 80% confluence, the adherent MSCs were detached with 0.25% trypsin and passed at a ratio of 1:3.

To determine proliferative ability, the cells were seeded in three 24-well plates (5,000 cells per well). After 48 h incubation, the cells were trypsinized to produce a single cell suspension and stained with 0.2% trypan blue. The viable cell number was counted with a hemocytometer (Qiujing Inc., Shanghai, China) under a phase-contrast microscope (CKX 41; Olympus Corporation, Tokyo, Japan). The average cell number was calculated from four wells from each of three plates and the cell counting procedure was repeated every 48 h.

Chemical reagents

Bafilomycin A1 (Baf A1) and 3-methyladenine (3-MA), purchased from Sigma-Aldrich (St. Louis, MO, USA) and Cayman Chemical (Ann Arbor, MI, USA) respectively, were used extensively for autophagic inhibition. To produce a stock solution, 1 mg Baf A1 and 30 mg 3-MA were dissolved in 1 ml dimethylsulfoxide and 1 ml double-distilled water, respectively. Future dilutions were performed in culture medium to obtain the desired concentrations. Acridine orange (A9231; Sigma-Aldrich) was used to detect autophagy.

Senescence-associated β-galactosidase assay

The cells were washed twice with phosphate-buffered saline (PBS) and stained using a senescence β-galactosidase (SA-β-gal) staining kit (Beyotime Biotech., Jiangsu, China), according to the manufacturer’s instructions. Senescent cells (SA-β-gal positive cells) were counted under an inverted microscope (CKX 41SF; Olympus Corporation, Tokyo, Japan) and data were expressed as the mean percentage of total cells from five independent wells.

Acridine orange staining

To monitor autophagy morphological characteristics, the formation of acidic vesicular organelles (AVOs) was quantified by acridine orange staining (12). MSCs were washed with PBS and stained with 1 μM acridine orange for 15 min at 37°C. Subsequent to further washing with PBS, the cells were examined and imaged under a fluorescence microscope (BX51; Olympus Corporation). Depending on acidity, autophagic lysosomes appeared as orange/red cytoplasmic vesicles, while the nuclei were stained green.

Protein extraction and western blot analysis

Subsequent to washing in ice-cold PBS, the cultures were immediately lysed in RIPA assay lysis buffer containing protease inhibitor. Total protein concentrations were quantified with a bicinchoninic protein assay kit (P0012S; Beyotime Biotech, Jiangsu, China). For western blotting, equal quantities of protein were separated in 16% SDS-polyacrylamide gels and electrophoretically transferred to polyvinylidene difluoride membranes. Subsequent to blocking with 5% non-fat milk, the membranes were incubated with specific primary antibodies (1:1,000 dilutions) against microtubule-associated protein 1A/1B-light chain 3 (LC3; 4108; Cell Signaling Technology, Inc., Danvers, MA, USA), Atg7 (8558; Cell Signaling Technology, Inc.), Atg12 (4180; Cell Signaling Technology, Inc.), p16 (SC-1661, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) or p21 (BS1269; Bioworld Technology, Inc., Minneapolis, MN, USA) overnight. The membranes were then washed three times with tris-buffered saline and Tween® (TBST), and incubated with horseradish peroxidase-conjugated secondary antibody (1:3,000 dilution; BS13278, Bioworld Technology, Inc.) for 1 h at room temperature. Following a further three washes with TBST, the bands were visualized by enhanced chemiluminescence.

RNA extraction and reverse transcription polymerase chain reaction (RT-PCR) analysis

Total RNA was isolated using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) and reverse-transcribed to cDNA using a PrimeScript RT reagent kit (Takara Bio, Inc., Shiga, Japan). RT-PCR was performed using a SuperReal Premix [Tiangen Biotech (Beijing) Co., Ltd., Beijing, China] on the Bio-Rad IQ2 Real-Time PCR system (Bio-Rad, Hercules, CA, USA). The relative gene expression levels were calculated by the 2−ΔΔCT method and the values were normalized to those of GAPDH. Each experiment was performed in triplicate. The specific primers used were: ATG7 forward: 5′-GAG GAG ACC GTC TGA GCA AC-3′ and reverse: 5′-TGA CAC AGG AAA GGG TGC AA-3′; ATG12 forward: 5′-AAA CGT GAG CCA AGG GGATT-3′ and reverse: 5′-GGA AAC TTG GTG CTG CTT GG-3′; GAPDH forward: 5′-GAT GGG TGT GAA CCA CGA GAAA-3′ and reverse: 5′-ACG GAT ACA TTG GGG GTA GGA-3′.

Transmission electron microscopy (TEM)

The cells were harvested with trypsin and fixed with 2.5% glutaraldehyde in 0.1 ml acodylate buffer (pH 7.4) for 2 h at 4°C. Following two washes in cacodylate buffer, the samples were post-fixed with 1% osmium tetroxide for 1 h at room temperature, then dehydrated in a growing gradient of ethanol and embedded in 812 epoxy resin (Polysciences, Inc., Warrington, PA, USA). Subsequently, 70 nm sections were cut on an ultra-microtome (SuperNova; LKB, Bromma, Sweden). The sections were post-stained with 2% uranyl acetate for 15 min and Reynald’s lead citrate for 15 min. The sections were imaged at 120 kV on a Tecnai G20 TEM (FEI, Hillsboro, OR, USA).

Statistical analysis

The Student-Newman-Keuls multiple comparison test, following either one-way analysis or Student’s t-test, was performed to evaluate the statistical significance with Sigma Plot 10.0 software (Systat Software, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.

Results

MSCs at higher passage exhibit senescent characteristics

Cells with colony-forming growth and fibroblast-like morphology were derived from passage 2 (P2). Proliferation was gradually reduced over the course of long-term cultivation until the cells became enlarged and flat, and stopped proliferating at P6. The cells at this stage exhibited significantly increased SA-β-gal activity, a biomarker of senescent cells in culture, with a >90% positive stain (Fig. 1A–C). Therefore, the cells were termed senescent MSCs. In addition, p16 and p21, senescence-related molecules, were markedly upregulated in senescent MSCs compared with MSCs at P2 (Fig. 1D).

Autophagic activity is upregulated during MSC senescence

To evaluate autophagic activity in senescent MSCs, autophagy was investigated by TEM, acridine orange staining and analysis of the levels of autophagy-related gene expression. Autophagic vacuoles were directly visualized by TEM. Autophagic vacuoles are identified by a double-membrane structure containing undigested cytoplasmic material, including organelles, as described by Mizushima et al (13). In the present study, senescent MSCs exhibited a greater number of autophagic vacuoles, predominantly located on one side of the nucleus, while MSCs at P2 exhibited a normal organization with a typical nucleus and a dense cytoplasm (Fig. 2A). Autophagy may also be demonstrated through the detection of autolysosomes, which are AVOs. Acridine orange-stained AVOs exhibted red punctation, with the nucleus stained green and the cytoplasm bright green. AVOs were observed in the MSCs at P2 and the senescent MSCs (Fig. 2A). LC3-II is closely associated with the autophagosomal membrane; monitoring LC3-II is widely used to assay the autophagic activity in cells. Accumulation of LC3-II indicates an elevated autophagic activity in senescent MSCs (Fig. 2B). Two other autophagy-associated effectors, Atg7 and Atg12, were also investigated by western blotting and RT-PCR. Senescent MSCs exhibited significantly increased expression levels of Atg7 and Atg12 protein and mRNA, compared with MSCs at P2 (Fig. 2B–D). These results therefore indicate that senescent MSCs exhibit high autophagic activity.

Inhibition of autophagy alleviates the senescent state of MSCs

Following cellular adherence for three days at P6, the senescent MSCs were treated with autophagic inhibitors (10 mm 3-MA and 5 nm Baf A1) for three days. Both 3-MA and Baf A1 inhibited autophagy, as shown by acridine orange staining where the AVOs were significantly reduced by autophagy inhibitor treatment (Fig. 3A). In addition, the expression levels of LC3 were reduced when senescent MSCs were treated with 3-MA (Fig. 3B). In Baf A1 treatment, autophagy was inhibited prior to autophagosome and lysosome fusion, thus LC3-II is not degraded through the fusion of autophagosomes and lysosomes (13). Therefore, in the MSCs, the LC3-II aggregation indicated that autophagy was suppressed.

Following confirmation that autophagy inhibitors efficiently suppress autophagy in senescent MSCs, the effect of these inhibitors on cell senescence was then analyzed. The rate of SA-β-gal-positive staining and the expression levels of senescence-related molecules were investigated to evaluate the senescent state of the cells treated with autophagy inhibitors. The rate of SA-β-gal-positive staining was significantly reduced following exposure to the autophagy inhibitors (Fig. 4A and B). Concomitant with the marked reduction in the activity of SA-β-gal, the expression levels of p16 and p21 proteins were also reduced in response to autophagy inhibitor treatment (Fig. 4C).

Discussion

MSCs have great potential in cell-based therapeutic applications and tissue engineering. However, due to the low cell frequencies in tissues and the restricted volume of obtainable tissues, MSCs are usually culture-expanded prior to applications (1,2). During long-term in vitro expansion, MSCs undergo a limited number of divisions and then cease proliferation. This is accompanied by a specific set of changes in cell physiology, morphology and gene expression, such as an enlarged and flattened morphology, increased SA-β-gal activity and the upregulation of senescence-related genes (3,14). In accordance with these features, in the present study, rat MSCs exhibited senescent characteristics at P6. This is consistent with previous studies (10). Although the senescent cells enter a prolonged growth-arrested state, the cells remain metabolically active.

Autophagy, a predominant intracellular degradation catabolic process, is important for the maintenance of tissue homeostasis in stress conditions (15,16). Although autophagy and senescence are generally considered to be two distinct cellular events, a number of studies have provided circumstantial evidence to indicate that the two are functionally intertwined. Sasaki et al (17) demonstrated that autophagy and senescence have been collaterally observed in the damaged bile ducts of patients with primary biliary cirrhosis. An increase in autophagic vacuoles was also evident in senescent endothelial cells (18), fibroblasts and human dental pulp cells (19,20). Recently, Goehe et al (9) reported that autophagy and senescence commonly occur in parallel following the treatment of MCF-7 breast tumor cells with chemotherapeutic drugs. Furthermore, Young et al (21) suggested that autophagy mediates the acquisition of oncogene-induced senescence.

To examine the effects of autophagic activity on MSC senescence in the present study, autophagy was inhibited by pharmacological methods. The lack of highly specific autophagy inhibitors is recognized as a problem in autophagy research. 3-MA, the most commonly used autophagy inhibitor, has been reported to inhibit the activity of phosphoinositide 3-kinase and block the formation of autophagosomes at the early stages of autophagy (22). Baf A1 alters lysosomal degradation by inhibiting acidification in later stages of autophagy (23). To avoid affecting other cell processes due to autophagic inhibition, 3-MA and Baf A1 were used as autophagy inhibitors in the present study. Attenuating autophagy activation contributed to reduced SA-β-gal activity and senescence-related molecule expression levels. However, a number of studies support an inverse association between autophagy and senescence (24,25). This discrepancy may result from differences in experimental conditions; those studies analyzed basal autophagy, which was observed in the absence of internal or external stress.

The results from the present study have demonstrated that autophagy is involved in MSC senescence. This provides novel insights into understanding the underlying mechanism of MSC senescence. The functional senescence cells produce certain molecules that act in a positive feedback loop to reinforce the senescent phenotype and this constitutes a danger signal, which affects the microenvironment and sensitizes normal neighboring cells to senescence (26,27). However, the efficient synthesis of these molecules requires autophagic protein degradation mechanisms (27). This indicates that autophagy modulates the functional activity of senescent MSCs. Results of the present study have shown that autophagy is activated during long-term MSC culture and a reduction in autophagic activity in senescent MSCs attenuates the senescent state. This result suggests that autophagic activity is a requirement for maintaining the senescent state of MSCs. The finding provides novel insights into the understanding of the senescent mechanism and a potential strategy for appropriate autophagy regulation that may counteract the senescence of MSCs. However, further studies are required in this field, particularly in the association between autophagy and senescence.

Acknowledgements

This study was supported by a grant from the National Natural Science Foundation of China (grant no. 81071269).

References

1 

Wagner W and Ho AD: Mesenchymal stem cell preparations - comparing apples and oranges. Stem Cell Rev. 3:239–248. 2007. View Article : Google Scholar : PubMed/NCBI

2 

Nery AA, Nascimento IC, Glaser T, et al: Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications. Cytometry A. 83:48–61. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Wagner W, Horn P, Castoldi M, et al: Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One. 3:e22132008. View Article : Google Scholar : PubMed/NCBI

4 

Rodier F: Detection of the senescence-associated secretory phenotype (SASP). Methods Mol Biol. 965:165–173. 2013. View Article : Google Scholar : PubMed/NCBI

5 

Narita M, Young AR and Narita M: Autophagy facilitates oncogene-induced senescence. Autophagy. 5:1046–1047. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Levine B and Klionsky DJ: Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI

7 

Levine B and Kroemer G: Autophagy in the pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Gewirtz DA: Autophagy and senescence: a partnership in search of definition. Autophagy. 9:808–812. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Goehe RW, Di X, Sharma K, et al: The autophagy-senescence connection in chemotherapy: must tumor cells (self) eat before they sleep? J Pharmacol Exp Ther. 343:763–778. 2012. View Article : Google Scholar

10 

Hu C, Wu Y, Wan Y, Wang Q and Song J: Introduction of hIGF-1 gene into bone marrow stromal cells and its effects on the cell’s biological behaviors. Cell Transplant. 17:1067–1081. 2008.PubMed/NCBI

11 

Zheng Y, He L, Wan Y and Song J: H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells. Stem Cells Dev. 22:256–267. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Chen Y, Azad MB and Gibson SB: Methods for detecting autophagy and determining autophagy-induced cell death. Can J Physiol Pharmacol. 88:285–295. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Mizushima N, Yoshimori T and Levine B: Methods in mammalian autophagy research. Cell. 140:313–326. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Bonab MM, Alimoghaddam K, Talebian F, et al: Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 7:142006. View Article : Google Scholar : PubMed/NCBI

15 

Cuervo AM, Bergamini E, Brunk UT, et al: Autophagy and aging: the importance of maintaining ‘clean’ cells. Autophagy. 1:131–140. 2005.

16 

Mizushima N: Autophagy: process and function. Genes Dev. 21:2861–2873. 2007. View Article : Google Scholar

17 

Sasaki M, Miyakoshi M, Sato Y and Nakanuma Y: Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis. Lab Invest. 90:835–843. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Kurz DJ, Decary S, Hong Y and Erusalimsky JD: Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci. 113:3613–3622. 2000.

19 

Gerland LM, Peyrol S, Lallemand C, et al: Association of increased autophagic inclusions labeled for beta-galactosidase with fibroblastic aging. Exp Gerontol. 38:887–895. 2003. View Article : Google Scholar : PubMed/NCBI

20 

Li L, Zhu YQ, Jiang L and Peng W: Increased autophagic activity in senescent human dental pulp cells. Int Endod J. 45:1074–1079. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Young AR, Narita M, Ferreira M, et al: Autophagy mediates the mitotic senescence transition. Genes Dev. 23:798–803. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Fleming A, Noda T, Yoshimori T and Rubinsztein DC: Chemical modulators of autophagy as biological probes and potential therapeutics. Nat Chem Biol. 7:9–17. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Kaminskyy V and Zhivotovsky B: Proteases in autophagy. Biochim Biophys Acta. 1824:44–50. 2012. View Article : Google Scholar : PubMed/NCBI

24 

Kang HT, Lee KB, Kim SY, Choi HR and Park SC: Autophagy impairment induces premature senescence in primary human fibroblasts. PLoS One. 6:e233672011. View Article : Google Scholar : PubMed/NCBI

25 

Fujii S, Hara H, Araya J, et al: Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease. Oncoimmunology. 1:630–641. 2012. View Article : Google Scholar : PubMed/NCBI

26 

Rodier F and Campisi J: Four faces of cellular senescence. J Cell Biol. 192:547–556. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Young AR and Narita M: Connecting autophagy to senescence in pathophysiology. Curr Opin Cell Biol. 22:234–240. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

December-2014
Volume 10 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zheng Y, Hu C, Zhuo R, Lei Y, Han N and He L: Inhibition of autophagy alleviates the senescent state of rat mesenchymal stem cells during long-term culture. Mol Med Rep 10: 3003-3008, 2014
APA
Zheng, Y., Hu, C., Zhuo, R., Lei, Y., Han, N., & He, L. (2014). Inhibition of autophagy alleviates the senescent state of rat mesenchymal stem cells during long-term culture. Molecular Medicine Reports, 10, 3003-3008. https://doi.org/10.3892/mmr.2014.2624
MLA
Zheng, Y., Hu, C., Zhuo, R., Lei, Y., Han, N., He, L."Inhibition of autophagy alleviates the senescent state of rat mesenchymal stem cells during long-term culture". Molecular Medicine Reports 10.6 (2014): 3003-3008.
Chicago
Zheng, Y., Hu, C., Zhuo, R., Lei, Y., Han, N., He, L."Inhibition of autophagy alleviates the senescent state of rat mesenchymal stem cells during long-term culture". Molecular Medicine Reports 10, no. 6 (2014): 3003-3008. https://doi.org/10.3892/mmr.2014.2624